Cargando…
Sulfonylurea antidiabetics are associated with lower risk of out‐of‐hospital cardiac arrest: Real‐world data from a population‐based study
AIMS: Out‐of‐hospital cardiac arrest (OHCA) mostly results from ventricular tachycardia/ventricular fibrillation (VT/VF), often triggered by acute myocardial infarction (AMI). Sulfonylurea (SU) antidiabetics can block myocardial ATP‐regulated K(+) channels (K(ATP) channels), activated during AMI, th...
Autores principales: | Eroglu, Talip E., Jia, Lixia, Blom, Marieke T., Verkerk, Arie O., Devalla, Harsha D., Boink, Gerard J.J., Souverein, Patrick C., de Boer, Anthonius, Tan, Hanno L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453495/ https://www.ncbi.nlm.nih.gov/pubmed/33896015 http://dx.doi.org/10.1111/bcp.14774 |
Ejemplares similares
-
Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based study
por: Eroglu, Talip E, et al.
Publicado: (2021) -
Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study
por: Eroglu, Talip E., et al.
Publicado: (2022) -
Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries
por: Eroglu, Talip E, et al.
Publicado: (2019) -
Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
por: Eroglu, Talip E, et al.
Publicado: (2022) -
Opioid use is associated with increased out‐of‐hospital cardiac arrest risk among 40 000‐cases across two countries
por: Eroglu, Talip E., et al.
Publicado: (2021)